King Faisal Specialist Hospital and Research
State-linked Saudi hospital and research institution operating campuses in Riyadh, Jeddah, Madinah and Almather, delivering tertiary and quaternary transplant, oncology, cardiac and genomic medicine to 4M+ patients a year, funded by patient billing and health insurance reimbursement.
- Company typePrivate
- Founded1975
- HeadquartersRiyadh, Saudi Arabia
- Headcount10,001+
- GTM typeB2C
- OfferingServices
What King Faisal Specialist Hospital and Research does
King Faisal Specialist Hospital and Research Centre (KFSH&RC) is a state-linked, non-traded healthcare and research institution founded in 1975 and headquartered in Riyadh, Kingdom of Saudi Arabia. It operates hospital campuses in Riyadh (over 1,500 inpatient beds, the flagship and main research center), Jeddah (approximately 470 beds, with a telemedicine network linked to Riyadh) and Madinah (a 300-bed smart hospital), and added Almather Hospital as a fourth site in August 2026. Care delivery is organized into named Centres of Excellence (Cancer, Organ Transplant, Heart, Genomics Medicine, Medical, Neuroscience, Surgical, Pediatrics & Women's, Clinical Services, Perioperative & Intensive Care) covering more than 65 specialties, with 1,092 organ transplants performed in a single year and 4M+ patients treated annually across 107+ nationalities by over 13,500 professionals drawn from more than 67 nationalities, including 1,750 doctors. Governance sits with a 13-member Board chaired by Mr. Mazin Alromaih (since 2023), whose membership includes the Ministry of Health, Ministry of Finance, Public Investment Fund, Center for National Health Insurance and the Council of Economic and Development Affairs; the entity has no disclosed parent, holding company or equity investors and trades as a non-listed institutional provider rather than a for-profit corporate.
The underlying technical base combines clinical, manufacturing and research assets. Surgical capability includes fully robotic and single-port robotic platforms that produced the world's first fully robotic heart transplant, the world's first fully robotic liver transplant and a world-first single-port robotic living donor liver resection, plus integrated robotic deep brain stimulation. In-house additive manufacturing (fused deposition modeling, stereolithography, digital light processing and multi-jetting) produces surgical planning models, biocompatible cutting guides, orthotics and prosthetics. Radiopharmaceuticals are manufactured on three on-site cyclotrons, supplying more than 30 PET and SPECT agents to around 50 hospitals in Saudi Arabia under international GMP and SFDA standards, and the Secondary Standards Dosimetry Laboratory operates as an IAEA-recognized Collaborating Centre and national/regional dosimetry reference. The research arm under Chief Research and Innovation Officer Prof. Jackie Y. Ying integrates biomarker discovery, multi-omics, bioinformatics and AI, with over 200 primary patents granted or pending (42 licensed to multinational and start-up companies) and an integrated genomic medicine model highlighted by Nature Genetics. Digital access runs through the Altakhassusi patient portal/app, e-Services, referral entry, the 199019 helpline, iLearn, Motamarat and the iSupplier portal; no public or partner-facing developer API is exposed.
Economically the institution runs a transaction-based clinical model: revenue comes from tertiary and quaternary patient care (beds, intensive care, surgery, transplantation, oncology, specialist consultations) collected through patient billing and third-party health insurance reimbursement, with billing and insurance data shared with insurers for payment and coverage, and a separate patient-accounts function operated through the Admission Office. Non-clinical lines are smaller but meaningful: radiopharmaceutical product supply to external hospitals (usage-based), clinical trial management and investigational therapeutics including sponsor-funded therapies (four high-impact partnership agreements plus roughly one new agreement annually, alongside CRO and contract research services), 3D printing services, comparative medicine contract research under AAALAC accreditation, and education and training programs spanning 66 residency and 27 fellowship tracks. Patient charges, insurance tariffs and research-service fees are not publicly disclosed, so pricing mechanics and payer mix are not observable from the source data.
King Faisal Specialist Hospital and Research firmographics
Firmographics- Name
- King Faisal Specialist Hospital and Research
- Legal name
- King Faisal Specialist Hospital and Research Center
- Website
- https://kfshrc.edu.sa
- Company type
- Private
- Founded year
- 1975
- Operating status
- Operating
- Headcount range
- 10,001+ employees
- Short description
- State-linked Saudi hospital and research institution operating campuses in Riyadh, Jeddah, Madinah and Almather, delivering tertiary and quaternary transplant, oncology, cardiac and genomic medicine to 4M+ patients a year, funded by patient billing and health insurance reimbursement.
- Ownership category
- akta.pro rank
King Faisal Specialist Hospital and Research industry classification
Industry- Product category
- Tertiary Care Hospital Services
- NAICS
- Hospitals (622), General Medical and Surgical Hospitals (6221), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)
- SIC
- Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Medical Laboratories (8071)
- akta.pro industry
- Oncology & Cancer Specialty HospitalsHealthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty CareCardiac & Cardiothoracic Specialty HospitalsHealthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty CareHospital-Integrated Cancer Centers (Acute Oncology Programs)Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)
Keywords
Where King Faisal Specialist Hospital and Research is headquartered
LocationHeadquarters
- HQ city
- Riyadh
- HQ country
- Saudi Arabia
- HQ region
- Middle East
Offices3 records
Markets served
King Faisal Specialist Hospital and Research business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Clinical services (patient care and treatment): Revenue is generated from the delivery of tertiary and quaternary clinical care across three hospital campuses (Riyadh, Jeddah, Madinah), including inpatient beds, intensive care, surgical programmes, organ transplantation, oncology and specialist consultations. Billing data (health data used for billing purposes) and insurance data (bank account details, health insurance details, credit/debit cards) are collected and shared with insurers for payment and coverage, indicating third-party payer reimbursement as a core collection mechanism.
- Radiopharmaceutical manufacturing (supply to hospitals): The Cyclotron and Radiopharmaceuticals unit produces on-demand ready-to-use doses of more than 30 radiopharmaceuticals supplied to around 50 hospitals throughout Saudi Arabia, under international GMP and SFDA standards — a product supply revenue line to external institutional customers.
- Clinical trials and investigational therapeutics: Clinical trial management services, including sponsor-funded investigational therapies and cost avoidance where trial participants receive industry-sponsored therapies that the institution would otherwise fund; includes four high-impact partnership agreements with one new agreement annually, plus CRO/contract research services.
- 3D printing and custom medical device services: Award-winning in-house 3D printing service offered to clinical and research departments and external organisations, covering surgical planning models, biocompatible cutting guides, orthotics and prosthetics, and research prototypes.
- Comparative medicine contract research organization services: Animal models, veterinary care and operating rooms made available to external organisations under contract and collaboration, including medical device testing, immune therapies and surgical innovation studies for local and international universities and hospitals.
- Education, training and professional development programs: Academic & Training Affairs runs undergraduate, postgraduate (66 residency and 27 fellowship programs), non-medical training, simulation centre and continuing medical education programs, plus scholarships, some with international accreditation, open to employees, interns/students and external organisations.
Go-to-market motion4 records
Distribution channels6 records
King Faisal Specialist Hospital and Research product offering
Product offeringCore offering
King Faisal Specialist Hospital & Research Centre provides tertiary and quaternary hospital care through three campuses in Riyadh, Jeddah and Madinah, covering inpatient beds, intensive care, surgical programmes, organ transplantation, oncology and specialist consultations across more than 65 specialties. Its care is organised into named Centres of Excellence (including Cancer, Organ Transplant, Heart, Genomics Medicine, Neurosciences, Surgical and Perioperative & Intensive Care) and is extended by an in-house Research Centre that sells contract research services such as clinical trials management, 3D printing, radiopharmaceutical manufacturing and dosimetry calibration.
Product overview
KFSH&RC operates not a single software product but a multi-campus healthcare and research platform: three hospital campuses (Riyadh, Jeddah, Madinah) plus the new Almather Hospital, organized into named Centres of Excellence (Cancer, Organ Transplant, Heart, Genomics Medicine, Medical, Neuroscience, Surgical, Pediatrics & Women's, Clinical Services and Perioperative & Intensive Care), supported by a set of standalone Research Services (Biomedical Physics, Clinical Trials, Comparative Medicine, Cyclotron and Radiopharmaceuticals, Investigational Therapeutics, Research Regulation and Compliance and 3D Printing) and a digital layer of patient-facing and staff-facing platforms (the Altakhassusi/KFSH App patient portal, e-Services, iLearn learning platform, Motamarat CME app, Health Sciences Digital Library and the iSupplier portal). On top of these foundations KFSH&RC layers a growing applied-AI product set (AI-powered ECG analysis, a CAR T-cell eligibility and risk assessment platform, and an applied AI ecosystem for radiology), alongside an in-house 3D printing service for precision surgery and robotic surgery platforms used in transplant and neurosurgical programs.
Differentiator
Problem solved
Functional benefit
Brands
- Altakhassusi (KFSH App): Patient mobile application and personal health records portal used to manage appointments, access medical records, view test results and find doctors; also published as the Altakhassusi medical record service.
- Motamarat
- iLearn
- Secondary Standards Dosimetry Laboratory (SSDL)
Products and services
- KFSH&RC Riyadh Hospital Flagship 1,500-bed hospital and main research centre of KFSH&RC, delivering advanced medical and surgical care for patients across Saudi Arabia and internationally, leading organ transplantation, cancer treatment and genomic medicine programmes; JCI-accredited and home of the world's first fully robotic heart transplant.
- KFSH&RC Jeddah Hospital Approximately 470-bed specialist care, training and research campus on the Red Sea coast with general and specialised wards, advanced cardiac care, paediatric surgery and oncology units, and a telemedicine network linked to Riyadh for complex consultations.
- KFSH&RC Madinah Hospital Newest 300-bed hospital in the network in the Holy City, featuring smart hospital systems, smart rooms, an infusion centre and operating theatres, with a focus on cancer, ophthalmology, critical care and women's health.
- Organ Transplant Centre of Excellence Twelve-specialty centre leading the Middle East in organ transplantation, performing 1,092 organ transplants in a single year, including the world's first fully robotic liver transplant, and the world's first single-port robotic living donor liver resection.
- Heart Centre of Excellence Five-specialty centre operating the only active heart transplant programme in the Kingdom of Saudi Arabia and the Gulf region and the largest in Asia Pacific, ranking among the top 10% of transplant centres worldwide; home of the world's first fully robotic heart transplant.
- Cancer Centre of Excellence Described as the Gulf's largest premier cancer facility with seven specialties, treating nearly a quarter of all cancer cases in Saudi Arabia annually, backed by the King Abdullah Center for Oncology and Liver Diseases (KACOLD) with 300 smart-room beds, 96 infusion centre beds and 8 operating theatres.
- Genomics Medicine Centre of Excellence Four-specialty centre applying genomic testing to tailor treatments to individual genetic profiles, linked to KFSHRC's integrated genomic medicine model that was highlighted by Nature Genetics as it scaled genomic medicine from research into clinical decision-making.
- Medical Centre of Excellence Eight expert teams under one roof spanning immunology, endocrinology, gastroenterology, infectious diseases, internal medicine, nephrology, pulmonary medicine and rheumatology.
- Neuroscience Centre of Excellence Eight-specialty multidisciplinary centre delivering treatments for brain tumours, stroke, epilepsy and movement disorders, including robotic deep brain stimulation and stereoelectroencephalography procedures.
- Surgical Centre of Excellence Six-specialty surgical centre covering minimally invasive and complex operations, supported by the hospital's integrated robotic surgery platform and by in-house 3D printing for surgical planning models and biocompatible cutting guides.
- Pediatrics & Women's Centre of Excellence Three-specialty centre offering specialised paediatric treatments, including the King Fahad National Centre for Children's Cancer and the largest regional paediatric stem cell transplant programme, and comprehensive women's health services for families.
- Clinical Services Centre of Excellence Clinical services hub within KFSH&RC's Centres of Excellence, grouping specialised clinical service lines delivered across the network's hospital campuses.
- Perioperative & Intensive Care Centre of Excellence Perioperative services and intensive care unit capability supporting complex surgery, including the Riyadh campus's advanced intensive care units.
- 3D Printing Service On-site additive manufacturing service using fused deposition modeling, stereolithography, digital light processing and multi-jetting, offered to clinical and research departments and external organisations for surgical planning models, biocompatible cutting guides, custom orthotics and prosthetics, and research prototypes and bioprinting.
- Clinical Trials Unit Central hub coordinating end-to-end clinical trial management from activation to completion for sponsors, CROs and investigators, advising on feasibility and trial operations; almost half of all active clinical trials in Saudi Arabia are conducted at KFSHRC.
- Cyclotron and Radiopharmaceuticals On-demand production of more than 30 different PET and SPECT radiopharmaceuticals using three on-site cyclotrons under international GMP and SFDA standards, supplying ready-to-use patient doses to around 50 hospitals throughout Saudi Arabia, with quality control covering radionuclide identification, radiochemical purity, pH, sterility and residual solvents.
- Biomedical Physics Department (incl. Secondary Standards Dosimetry Laboratory) Medical physics, radiation protection, quality assurance, calibration and dosimetry services; its Secondary Standards Dosimetry Laboratory is an IAEA-recognised Collaborating Centre and a national and regional reference centre for radiation dosimetry providing traceable calibration to international primary standards.
- Comparative Medicine AAALAC-accredited animal model and veterinary care facility supporting biomedical research, medical device testing, immune therapies and surgical innovation studies, with animal models, veterinary care and operating rooms made available to external universities, hospitals and organisations under contract and collaboration, plus reproductive biology and infertility biomarker research.
- Investigational Therapeutics Department Department overseeing investigational therapies from discovery through real-world evidence generation, managing industry and CRO partnerships, trial training programmes and digital enablement such as Arabic-language patient portals, including sponsor-funded investigational therapies and cost avoidance where trial participants receive industry-sponsored therapies.
- Altakhassusi (KFSH App) patient portal and mobile app Secure patient-facing portal and mobile app (iOS and Android) for patients to manage appointments, access medical records and Personal Health Records, view test results, find doctors and follow up after visits.
- e-Services (General and Patient e-Services) Online hospital services covering appointment booking, referral initiation, patient information and family or visitor guidance, delivered through the web portal and the KFSH App, including self-booking of appointments and access to test results and medical records 24/7.
- iLearn Learning Management System KFSHRC's learning management system giving staff and students anytime access to courses, training materials and professional development resources across more than 200 specialised training programmes.
- Motamarat Custom-built application for managing continuing medical education conferences, workshops and courses with streamlined registration and certification for clinicians and external participants.
- AI-Powered ECG Analysis In-house AI capability developed by KFSHRC to analyse electrocardiograms, supporting early detection of cardiac conditions and clinical decision-making for the hospital's clinical teams.
- AI Platform for CAR T-Cell Therapy Eligibility and Risk Assessment AI platform that assesses patient eligibility for CAR T-cell therapy and produces risk assessments from clinical and laboratory records, part of KFSHRC's applied-AI portfolio for haematologic oncology.
- Applied AI Ecosystem in Radiology Hospital-wide model for deploying artificial intelligence across radiology workflows, positioning AI as core infrastructure for image interpretation and for scaling tertiary care transformation beyond pilots.
- Integrated Robotic Surgery Platform Robotic surgery capability deployed across specialties, including the integrated robotic system used for deep brain stimulation and the single-port robotic systems used for liver transplant and living donor liver resection procedures.
Quantifiable outcome
- Reduced cost of CAR-T therapy by 80 percent
- +9 more outcomes
Companies that use King Faisal Specialist Hospital and Research
Customer profileNamed customers3 records
Ideal customer profiles5 records
King Faisal Specialist Hospital and Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability9 records
Feature13 records
King Faisal Specialist Hospital and Research partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered flagship strategic technology partnership to advance healthcare innovation in saudi arabia, major network expansion in the eastern region, core vendor relationship for computing infrastructure, flagship annual industry forum participation, global forum participant / thought-leadership partnership, international policy dialogue participation, silver sponsorship of the milken institute global conference 2026, flagship global strategic partner designation, flagship national development project partnership, core international research alliance membership, core national research collaboration, core academic affiliation for medical education and secondary academic affiliation for medical education.
- Oracleflagship strategic technology partnership to advance healthcare innovation in saudi arabiaOracle and King Faisal Specialist Hospital & Research Centre announced a collaboration to advance healthcare innovation in Saudi Arabia. Announced via Oracle's own newsroom on 2026-10-01 and distributed via WebWire on 2026-10-02. The partnership builds on KFSHRC's position of artificial intelligence as core infrastructure in healthcare delivery and its integrated digital systems agenda under Deputy Group CEO Dr. Björn Zoëga.
- Almather Hospitalmajor network expansion in the eastern regionH.E. Dr. Majid Alfayyadh, Group CEO of KFSHRC, inaugurated Almather Hospital in connection with King Faisal Specialist Hospital & Research Centre, extending the KFSH&RC network and clinical model to a new hospital site.
- Axelerated Solutionscore vendor relationship for computing infrastructureAxelerated Solutions signed a computing services contract with KFSHRC. The agreement provides computing services to King Faisal Specialist Hospital & Research Centre, supporting the hospital's technology infrastructure and integrated digital systems.
- HLTH Europe 2026flagship annual industry forum participationKFSH showcased its applied AI ecosystem in radiology and its innovation infrastructure as the foundation for sustainable healthcare transformation at HLTH Europe 2026, emphasising capability building and the strategic value of tertiary care AI datasets for precision medicine.
- World Economic Forumglobal forum participant / thought-leadership partnershipKFSH joined the World Economic Forum Annual Health Roundtable 2026 to advance global dialogue on AI in healthcare, and spotlighted the rise of emerging AI-health leaders at the roundtable.
- Trilateral Commissioninternational policy dialogue participationKFSH joined global leaders at the Trilateral Commission Tokyo Plenary Meeting to shape the future of AI and digital healthcare, showcasing Saudi healthcare innovation and calling for scaling AI beyond pilot programs.
- Milken Institutesilver sponsorship of the milken institute global conference 2026KFSH participated in the Milken Institute Global Conference 2026 in Beverly Hills, California as a Silver Sponsor, bringing an AI-as-infrastructure approach to healthcare and extending care across a national network.
- C3 Davos of Healthcareflagship global strategic partner designationKFSH joined C3 Davos of Healthcare 2026 in Sunnyvale, California as a Global Strategic Partner, showcasing a scalable AI integration model and awarding winners of the KFSH Innovation Challenge at the Silicon Valley Summit.
- Qiddiyaflagship national development project partnershipQiddiya teamed up with KFSH to set up a premium sports medical centre in Riyadh. The partnership extends KFSH&RC's specialised tertiary care model into the Kingdom's sports and entertainment ecosystem, aligned with the Qiddiya giga-project development.
- Global Alliance for Genomics and Healthcore international research alliance membershipKFSH joined a prestigious global alliance for genomics and health, extending its genomic medicine programme and international standards alignment in genomic data sharing and clinical translation.
- King Abdulaziz City for Science and Technology (KAUST)core national research collaborationKFSH&RC is one of the leading centres of the Saudi Human Genome Program supported by KAUST. KFSH researchers collaborate with KAUST, whose researchers innovate stain-free imaging technology to accelerate cancer diagnosis in work described in the 'Stain-Free Imaging Platform from KAUST Enhances Cancer Diagnostics' release.
- Alfaisal Universitycore academic affiliation for medical educationMedical students attend an arranged clinical training medical programme in collaboration with Alfaisal University during their 4th-5th year, and KFSH&RC's training programmes are affiliated with Alfaisal University.
- Princess Nora bin Abdulrahman Universitysecondary academic affiliation for medical educationKFSH&RC's Undergraduate Medical Education coordinates with affiliated universities, including Princess Nora bin Abdulrahman University, to accept visiting medical students for clinical training.
Scale indicators20 records
Recent moves10 records
Expansion highlights8 records
King Faisal Specialist Hospital and Research competitors and assessment
Company assessmentRegional players
- King Abdullah Specialized Children’s Hospital: Saudi tertiary children's hospital in Riyadh operating oncology, transplant and paediatric specialty programmes under the same Ministry of Health ecosystem, making it the closest domestic comparator for complex paediatric and cancer care volumes.
- King Fahad Medical City: Saudi Arabia's largest tertiary referral complex with organ transplant, oncology and cardiac programmes and an embedded research arm — directly competing for national and international referral volumes.
- King Saud University Medical City: Riyadh-based academic medical centre combining tertiary hospital, teaching and research functions, structurally similar to KFSHRC's hospital-plus-research-centre model and competing for academic affiliation and clinical trial sites.
- Cleveland Clinic Abu Dhabi: Multi-specialty tertiary and quaternary hospital in the Gulf serving regional and international patients with transplant, cardiac and oncology care, a direct competitor for medical-tourism and complex-case referrals.
- Sheikh Khalifa Medical City (SKMC): UAE flagship tertiary hospital and academic centre with transplant, oncology and clinical trial programmes plus an in-house medical education academy — closely comparable in scale and service mix.
Broad incumbents
- Charité – Universitätsmedizin Berlin: University hospital with dedicated Centres of Excellence in oncology, transplant and cardiovascular care, a benchmark for the specialised-centre structure and outcome-transparency model KFSHRC is building.
- Royal Marsden NHS Foundation Trust: World-specialist cancer centre with large trial and genomics programmes; its CEO sits on the KFSHRC board, making it both a benchmark peer and a governance reference.
- Johns Hopkins Medicine: Academic medical centre integrating hospital, research and clinical trial operations at global scale, comparable for translational research infrastructure and international referral capture.
Others
- Siemens Healthineers: Supplies imaging, radiopharmacy and clinical technology to hospitals globally, an ecosystem participant positioned to partner with or compete against in-house capabilities such as KFSHRC's cyclotron manufacturing and radiology AI.
- GE HealthCare: Provides imaging equipment, radiopharmaceutical distribution and AI imaging software to hospital customers, overlapping with KFSHRC's radiology AI ecosystem and nuclear medicine supply chain.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat7 records
Key risks7 records
Key highlights7 records
Customer concentration
King Faisal Specialist Hospital and Research social profiles
Digital presenceKing Faisal Specialist Hospital and Research compliance and trust
Trust signalCompliance11 records
King Faisal Specialist Hospital and Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
King Faisal Specialist Hospital and Research leadership team
Management profileNumber of profiles
Profiles14 records
King Faisal Specialist Hospital and Research subsidiaries and ownership
Company hierarchySubsidiaries1 record
King Faisal Specialist Hospital and Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
King Faisal Specialist Hospital and Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about King Faisal Specialist Hospital and Research
What does King Faisal Specialist Hospital and Research do?
King Faisal Specialist Hospital & Research Centre provides tertiary and quaternary hospital care through three campuses in Riyadh, Jeddah and Madinah, covering inpatient beds, intensive care, surgical programmes, organ transplantation, oncology and specialist consultations across more than 65 specialties. Its care is organised into named Centres of Excellence (including Cancer, Organ Transplant, Heart, Genomics Medicine, Neurosciences, Surgical and Perioperative & Intensive Care) and is extended by an in-house Research Centre that sells contract research services such as clinical trials management, 3D printing, radiopharmaceutical manufacturing and dosimetry calibration.
Is King Faisal Specialist Hospital and Research a public or private company?
King Faisal Specialist Hospital and Research is a private company. It is classified as state government owned and is currently operating.
When was King Faisal Specialist Hospital and Research founded?
King Faisal Specialist Hospital and Research was founded in 1975. It employs 10,001+ people.
Where is King Faisal Specialist Hospital and Research based?
King Faisal Specialist Hospital and Research is headquartered in Riyadh, Saudi Arabia, in the Middle East region.
How does King Faisal Specialist Hospital and Research make money?
Six revenue lines are on record. Clinical services (patient care and treatment) is the primary driver. The others are radiopharmaceutical manufacturing (supply to hospitals), clinical trials and investigational therapeutics, 3D printing and custom medical device services, comparative medicine contract research organization services and education, training and professional development programs.
Who are King Faisal Specialist Hospital and Research's main competitors?
Regional players on record are King Abdullah Specialized Children’s Hospital, King Fahad Medical City, King Saud University Medical City, Cleveland Clinic Abu Dhabi and Sheikh Khalifa Medical City (SKMC). Broad incumbents are Charité – Universitätsmedizin Berlin, Royal Marsden NHS Foundation Trust and Johns Hopkins Medicine. Others are Siemens Healthineers and GE HealthCare.
Does King Faisal Specialist Hospital and Research have an API?
No public API is recorded for King Faisal Specialist Hospital and Research.
What industry is King Faisal Specialist Hospital and Research in?
King Faisal Specialist Hospital and Research's product category is Tertiary Care Hospital Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFAHAA, Cardiac & Cardiothoracic Specialty Hospitals. Its NAICS code is 622 and its SIC code is 8060.